Research

The Fagerholm group studies the role of leukocyte integrins in various immune reactions.

We are interested in the in vivo roles and regulation of leukocyte beta2-integrins in a healthy and dysfunctional immune system.

Integrin-mediated cell adhesion, migration and signalling is crucial for proper immune system function. Integrins regulate leukocyte functions such as lymphocyte recirculation, access of leukocytes into inflamed tissue, phagocytosis, immune cell signaling, T cell activation and effector functions. Investigations of the regulation of integrins are therefore fundamental for our understanding of immune system function in health and disease. In addition, integrins are recognized therapeutic targets in the intervention with human disease. Our group is interested in the in vivo roles and regulation of leukocyte beta2-integrins in a healthy and dysfunctional immune system.

Immune cell trafficking in health and disease

Immune cells constantly traffic around the body, looking for infection. For example, immune cells such as neutrophils and T cells need to exit the blood stream and enter tissues to perform their functions, such as killing bacteria, virus-infected cells or tumor cells. The importance of beta2-integrins for immune responses is shown by the rare genetic disorders, leukocyte adhesion deficiency (LAD) type I and III, where integrin expression or function is lost. In LAD-III, integrins are normally expressed but do not function properly because an important cytoplasmic regulator of integrins, called kindlin-3, is mutated. Patients with these disorders suffer from recurrent bacterial infections because of deficient immune cell trafficking and function.

Our laboratory is interested in molecular mechanisms regulating immune cell trafficking in homeostasis and inflammation.  We have created a novel mouse model to investigate the role of the integrin regulator kindlin-3 in vivo. In the mouse model the integrin/kindlin link has been disrupted. We have shown that the integrin-kindlin link is necessary for immune cell adhesion and trafficking both in homeostasis and in skin inflammation, and also for optimal T cell activation in vivo. We are currently investigating the molecular mechanisms involved in integrin/kindlin-mediated regulation of immune cell adhesion. We are also investigating the role of other integrin regulators in immune cell trafficking and functions in vivo, using transgenic mouse models.

References

Morrison VL, MacPherson M, Savinko T, Lek HS, Prescott A, Fagerholm SC. The β2 integrin-kindlin-3 interaction is essential for T-cell homing but dispensable for T-cell activation in vivo. Blood. 2013 Aug 22;122(8):1428-36. doi: 10.1182/blood-2013-02-484998. http://www.bloodjournal.org/content/122/8/1428

Morrison VL, Uotila LM, Llort Asens M, Savinko T, Fagerholm SC. Optimal T Cell Activation and B Cell Antibody Responses In Vivo Require the Interaction between Leukocyte Function-Associated Antigen-1 and Kindlin-3. J Immunol. 2015 Jul 1;195(1):105-15. doi: 10.4049/jimmunol.1402741. http://www.jimmunol.org/content/195/1/105.full

Savinko TS, Morrison VL, Uotila LM, Wolff CH, Alenius HT, Fagerholm SC. Functional Beta2-Integrins Restrict Skin Inflammation In Vivo. J Invest Dermatol. 2015 Sep;135(9):2249-57. doi: 10.1038/jid.2015.164. http://www.jidonline.org/article/S0022-202X%2815%2939013-8/abstract

The immunoregulatory role of leukocyte integrins

Dendritic cells are the main antigen presenting cells in the immune system, and play an important role in “kicking off” the immune response. Interestingly, our work has shown that integrins play a novel role in dendritic cells; these receptors restrict dendritic cell activation, programming of the dendritic cell to a migratory phenotype and migration from tissues to lymph nodes in vivo. As a result, when integrins in dendritic cells are nonfunctional, this leads to increased T cell activation in vivo. In addition, mice where beta2-integrins are dysfunctional display increased skin inflammation in vivo.

These results show that integrins play important immunoregulatory roles in vivo. We are currently investigating the molecular mechanisms involved in beta2-integrin-mediated immunomodulation, using transgenic mouse models and novel proteomic methods.

References

Morrison VL, James MJ, Grzes K, Cook P, Glass DG, Savinko T, Lek HS, Gawden-Bone C, Watts C, Millington OR, MacDonald AS, Fagerholm SC. Loss of beta2-integrin-mediated cytoskeletal linkage reprogrammes dendritic cells to a mature migratory phenotype. Nat Commun. 2014 Oct 28;5:5359. doi: 10.1038/ncomms6359. http://www.nature.com/articles/ncomms6359

Savinko TS, Morrison VL, Uotila LM, Wolff CH, Alenius HT, Fagerholm SC. Functional Beta2-Integrins Restrict Skin Inflammation In Vivo. J Invest Dermatol. 2015 Sep;135(9):2249-57. doi: 10.1038/jid.2015.164. http://www.jidonline.org/article/S0022-202X%2815%2939013-8/abstract

β2-integrins as regulators of dendritic cell anti-tumor responses

Our work has shown that bone marrow-derived dendritic cells deficient in β2 integrin adhesion adopt a mature phenotype. Interestingly, we have now shown that these cells induce an increased CD8+ T cell response, and lead to enhanced tumor rejection in mouse melanoma models (B16.OVA and B16-F10). We have identified a transcription factor network including RelA and Ikaros, as well as epigenetic changes (H3K4Me3 histone methylation) involved in the integrin-regulated reprogramming of dendritic cells into the mature, migratory phenotype able to drive increased tumor rejection in vivo. We suggest that targeting integrin-regulated dendritic cell reprogramming could have a great impact on cancer immunotherapy research.

References:

Guenther C, Faisal I, Fusciello M, Sokolova M, Harjunpää H, Ilander M, Tallberg R, Vartiainen MK, Alon R, Gonzalez-Granado JM, Cerullo V, Fagerholm SC. β2-Integrin Adhesion Regulates Dendritic Cell Epigenetic and Transcriptional Landscapes to Restrict Dendritic Cell Maturation and Tumor Rejection. Cancer Immunol Res. 2021 Nov;9(11):1354-1369. doi: 10.1158/2326-6066.CIR-21-0094. Epub 2021 Sep 24. PMID: 34561280.: https://pubmed.ncbi.nlm.nih.gov/34561280/

Harjunpää H, Llort Asens M, Guenther C, Fagerholm SC. Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment. Front Immunol. 2019 May 22;10:1078. doi: 10.3389/fimmu.2019.01078. PMID: 31231358; PMCID: PMC6558418.: https://pubmed.ncbi.nlm.nih.gov/31231358/